Aldossary, Faisal Hammad, Alhammar, LolowahEbraheem, Abdalqadir, Dhoha Ibrahim Al, Alabdalqadir, Danah Ibrahim, Aloyaid, Abdullah Saud, Alobaid, Abdullah Khalid, Alhammar, AmnahEbraheem, Alharbi, Abdulaziz Abdullah Mohammed, Alotaibi, Mohammad Abdullah, Khalaf, Renad Mohammed, and Alenazi, Abdulrahman Abdullah
The Egyptian Journal of Hospital Medicine. Jan 6, 2018, Vol. 70 Issue 6, p935, 4 p.
Dyslipidemias -- Development and progression, Dyslipidemias -- Care and treatment, Primary health care -- Methods, Medical research, and Medicine, Experimental
INTRODUCTION Managing dyslipidemia is an essential part of most practice guidelines with several variations between these guidelines. However, usually these guidelines are not followed widely on the level of primary [...] Introduction: Management of dyslipidemia is an important part of most practice guidelines with many variations between these guidelines. Unfortunately, usually these guidelines are not followed widely on the level of primary care, possibly due to insufficient qualification of health care staff in primary care, non-participation in recent guidelines, and unrealistic target assigned to patients that leads them to non-compliance with medication and follow-up. Methodology: We conducted this review using a comprehensive search of MEDLINE, PubMed, and EMBASE, January 2001, through February 2017. The following search terms were used: dyslipidemia, primary health care dyslipidemia management, follow-up of dyslipidemia. Aim: In this review, we aimed at evaluating the management expected from primary health care for risk assessment, treatment and follow-up of patients with dyslipidemia. Conclusion: Many guidelines exist for the proper management of dyslipidemia in the primary care setting. Screening is crucial for preventing the cardiovascular sequelae of dyslipidemia. Management modalities include lifestyle modification and pharmacotherapy, while the significance of follow-up cannot be neglected. Keywords: primary health care dyslipidemia management, follow-up of dyslipidemia, statin therapy, non-statin therapy